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Of the 32 bacterial species of staphylococci, Staphylococcus aureus is the 
most important as it is the most common member to be associated with 
staphylococcal infections and intoxication (Bergdoll 1989).  Since the first 
observance of S. aureus in the early 1800’s, the pathogen has been implicated in 
a variety of illnesses including nosocomial infections and foodborne intoxication.  
Staphylococcus aureus is an especially pathogenic microorganism because it 
possesses a variety of virulence factors that allow it not only to attach to host 
cells, but invade tissues and evade the host’s immune system (Freeman-Cook 
and Freeman-Cook 2006).   
Mammals, including humans, are the primary reservoir of the organism allowing 
for easy transfer of the microbe leading to nosocomial infections as well as the 
contamination of foods (Freeman-Cook and Freeman Cook 2006; Bergdoll 
1989).  The most important feature of some strains of S. aureus is the ability to 
produce potent, heat stable enterotoxins that not only display emetic properties 
but also act as super antigens, thus increasing the virulence of the organism.  
Enterotoxigenic strains of S. aureus are capable of producing up to 9 
serologically different enterotoxins as well as a variety of enterotoxin-like 
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substances that are capable of causing severe illness in humans (Thomas and 
others 2007).  Illness due to staphylococcal intoxication is usually acquired 
through ingestion of contaminated foods that contain preformed toxins and is the 
third most common cause of food poisoning in the world (Atanassova and others 
2001).  Because of the unique characteristics of the staphylococcal enterotoxins, 
mainly their ability to resist heat inactivation, they are extremely difficult to 
eliminate from foods in which they have all ready formed (Schantz and others 
1965; Fung and others 1973).  When this characteristic is paired with the fact that 
enterotoxin is rarely detected in foods until a large number of consumers become 









 Alexander Ogston first observed the staphylococci while performing 
experiments to prove his theory that cocci were pathogenic microorganisms and 
played a fundamental role in the formation of pus-filled infections, mainly 
abscesses (Bergdoll 1989).  Ogston was able to stain the cocci using methyl-
aniline which allowed him to study the different types of cocci in reference to their 
growth forms.  He described the cocci, which he named Staphylococcus, as 
being “individual spheres in masses [that] looked like bunches of grapes”.  
Ogston was further able to demonstrate a causal relationship between the 
micrococci and the formation of pus when he fulfilled Koch’s postulates by 
injecting mice with pus from abscesses and was able to recreate the original 
infection (Ogston 1984).  In 1804, Rosenbach isolated Ogston’s cocci from pus 
and is credited with describing the bacterial genus Staphylococcus and naming 
the organism Staphylococcus aureus for the yellow pigmentation it produced 
(Bergdoll 1989).   
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The staphylococci were not originally accepted as an individual genus by many 
microbiologists, and were instead classified in the genus Micrococcus.  However, 
Staphylococcus was eventually recognized as an individual genus in the 7th 
edition of Bergey’s Manual of Determinative Bacteriology based on such factors 
as its ability to grow anaerobically, its cell wall structure and its fatty acid profile 
(Bergdoll 1989).   
Characteristics 
 Staphylococcus aureus is a Gram positive coccus-shaped microorganism 
that generally occurs in grape-like clusters, but can also be found in singles and 
pairs (Tortora and others 2002; Ryan 2004).  Cells are non-motile, lack flagella 
and do not form spores, though they are able to survive in a dormant state for 
years under unfavorable conditions (Ryan 2004; Freeman-Cook and Freeman-
Cook 2006).  Staphylococcus aureus grows best under aerobic conditions but is 
able to employ a fermentative metabolism, making it a facultative anaerobe.  The 
organism is able to utilize several different carbohydrates during respiration.  
However, under anaerobic conditions, S. aureus will typically ferment glucose 
resulting in the production of lactic acid (Minor and Marth 1976).   
 Members of the species grow in the presence of salt, under high osmotic 
pressure, low moisture and at wide pH and temperature ranges (Tortora and 
others 2002; Freeman-Cook and Freeman-Cook 2006).  Staphylococcus aureus 
has been shown to grow readily in media containing 5% NaCl and many strains 
have demonstrated the ability to grow in the presence of 10 to 15% salt (Minor 
and Marth 1976).  Research conducted by Potter and Leistner found that S. 
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aureus can grow at a water activity as low as 0.864 though enterotoxin is usually 
not produced below 0.90 (1978).  Staphylococcus aureus is able to grow in a pH 
range from 4.2 to 9.3 and in a temperature range from 6.5 to 50º C with an 
optimum growth temperature of 30 to 40º C (Baird-Parker 1965). 
As with all Gram-positive bacteria, the cell wall contains peptidoglycan; 
however, it is also contains ribitol-teichoic acid molecules that are specific to S. 
aureus and act as antigens (Ryan 2004).  In addition to the presence of ribitol-
teichoic acid in the cell wall of S. aureus, some strains may also exhibit the 
presence of protein A, that can comprise up to 7% of the cell wall and may coat 
the outside of the cell (Gao and Stewart 2004).  Both ribitol-teichoic acid and 
protein A work to increase the virulence of the microorganism (Ryan 2004).  The 
cell wall of S. aureus is also very thick in comparison with other Gram-positive 
bacteria.  This increased thickness provides the organism with a very high 
internal pressure making it nearly impossible for many antimicrobial drugs to 
enter the cell (Freeman-Cook and Freeman-Cook 2006). 
Staphylococcus aureus can be easily distinguished from pathogenic 
streptococci by its production of catalase.  However, it is relatively similar to the 
other less virulent staphylococci.  Due to this similarity S. aureus must be 
distinguished via diagnostic tests.  Most strains of S. aureus will exhibit β-
hemolysis when grown on blood agar which can be a distinguishing 
characteristic.  However, the production of the enzyme coagulase is the most 
common distinguishing factor for S. aureus.  Coagulase binds to prothrombin in 
the blood causing fibrin to be polymerized, resulting in the formation of a clot 
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(Ryan 2004).  The coagulase produced by S. aureus is considered a determinant 
of the pathogenicity of the organism (Halpin-Dohnalek and Marth 1989).  
Virulence Factors 
Staphylococcus aureus possesses several virulence factors that can be 
placed into three broad categories:  attachment, evasion of the host immune 
response and invasion of host tissue.  No one factor can be held solely 
responsible for an infection, but rather it is the sum of all of the organism’s 
virulence factors that make S. aureus such a successful pathogen (Freeman-
Cook and Freeman-Cook 2006). 
Adherence to host cells is the first hurdle that S. aureus must overcome 
because the pathogen must be able to attach to a host surface in order for 
colonization or infection to occur (Freeman-Cook and Freeman-Cook 2006).  
Staphylococcus aureus usually accomplishes this adhesion by utilizing surface 
protein binding mechanisms such as fibronectin-binding and collagen-binding 
(Foster and Höök 1998).   Fibronectin-binding occurs when one of two 
fibronectin-binding proteins, FnBPA and FnBPB, produced by S. aureus 
negotiates the attachment of the bacterial cells to fibronectin in plasma clots and 
foreign materials, such as heart valves, within the body (Jönsson and others 
1991; Foster and Höök 1998).  Collagen-binding works in much the same way as 
fibronectin-binding where the staphylococcal binding protein, Cna, allows the 
bacterial cells to bind to collagen-containing tissues such as cartilage (Switalski 
and others 1989).  However, collagen-binding via Cna is less common because 
not all strains of S. aureus produce the protein (Foster and Höök 1998).  In order 
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to ease the attachment process, many strains will seek out blood clots or 
wounded tissue (Freeman-Cook and Freeman-Cook 2006). 
Once the pathogen has attached to the host cells, it must find a way to 
escape the resulting immune response.  Staphylococcus aureus does this 
through the production of specific enzymes, proteins, extracellular structures and 
superantigens (Freeman-Cook and Freeman-Cook 2006).  As a defense against 
infection, host cells will often release lipids capable of disrupting bacterial 
membranes.  In order to circumvent this mechanism, S. aureus produces the 
enzyme lipase to break down the lipids before they can attack the cell membrane 
(Freeman-Cook and Freeman-Cook 2006).  This action gives the pathogen time 
to solidify its adherence and begin multiplying, thus aiding in the spread of the 
organism (Rooijakkers and others 2005; Foster 2005).  The hallmark of the 
human immune system is the production of antibodies that mark infecting 
bacteria for destruction by white blood cells.  To counteract this action S. aureus 
cells excrete proteases: enzymes that are able to inactivate antibodies by 
digesting them into smaller pieces (Freeman-Cook and Freeman-Cook 2006; 
Foster 2005).  
Staphylococcus aureus also produces protein A, which interacts with 
antibodies to aid in the avoidance of phagocytosis (Freeman-Cook and Freeman-
Cook 2006; Dossett and others 1969).  Protein A is anchored into the bacterial 
cell wall and is also excreted by the cell into the surrounding environment.   
Protein A anchored in the cell wall binds to the Fc region of IgG causing the 
antibodies to adhere to one another and bind to their complement, resulting in 
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their inability to bind to the bacterial cell and mark it for phagocytosis (Foster 
2005; Freeman-Cook and Freeman-Cook 2006).  Additionally, the freely excreted 
protein A binds to the antibodies adhered to the surface of the bacteria and acts 
as a sort of smoke screen to hide the cell from new antibodies (Freeman-Cook 
and Freeman-Cook 2006).  A study conducted by Dossett and others found that 
there is an association between the concentration of protein A produced by the 
cell and its resistance to phagocytosis; thus, those strains that produce higher 
amounts of the protein are more likely to survive within the host (1969).  
Furthermore, it has been shown that protein A is only successful against IgG 
antibodies and can actually quicken the phagocytic process when other 
immunoglobulins are involved (Peterson and others 1977).   
Lastly, S. aureus can avoid phagocytosis by producing a cell wall capsule, 
or by aggregating into a biofilm.  Production of a thin polysaccharide capsule 
effectively hides the cell because antibodies are not able to bind to the cell wall 
nor are white blood cells able to recognize it as being pathogenic (Foster 2005; 
Freeman-Cook and Freeman-Cook 2006).  Though researchers know that S. 
aureus is able to produce a capsule and that it plays a role in pathogenicity, it is 
still unclear how the organism produces the capsule and under what precise 
conditions (Honeyman and others 2001). Alternatively, when bacteria join to form 
a biofilm on an artificial surface within the body, they are sheltered by a layer of 
polysaccharides that prevents antibodies and white blood cells from reaching 
them (Freeman-Cook and Freeman-Cook 2006). 
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The last method by which S. aureus is able to evade the immune system 
is through the production of superantigens.  Superantigens are exotoxins 
produced by the cell that are able to activate large numbers of T cells, by binding 
to the T cells β-chain, resulting in an over-release of the cytokine interleukin-2 
(Holtfreter and Bröker 2005; Honeyman and others 2001; Freeman-Cook and 
Freeman-Cook 2006).   An increased level of interleukin-2 in the body generally 
leads to fever and vomiting, but in some cases the immune response may 
become severe enough to result in multiple organ failure (Freeman-Cook and 
Freeman-Cook 2006).  Once the over-activation of T cells has occurred, the 
immune system of the host becomes suppressed and is unable to produce 
antibodies against the toxins or the bacterial cells leading to the further spread of 
the microorganism (Foster 2005).  Staphylococcus aureus is capable of 
producing 19 different superantigens, including the staphylococcal enterotoxins, 
which affect T cells in different ways.  Because more than one superantigen can 
be produced by a cell at the same time, it can have a devastating effect on the 
immune system of the host (Holtfreter and Bröker 2005; Choi and others 1989).  
The last category of virulence factors exhibited by S. aureus includes 
those that aid the organism in invading host tissues.  In order for a 
staphylococcal infection to spread, the pathogen must break down surrounding 
tissues that act as a physical barrier.  In the case of S. aureus this process is 
carried out primarily by the protein α-toxin, also known as alpha-hemolysin 
(Honeyman and others 2001).  Alpha-hemolysin works by infiltrating the lipid 
bilayer of the host tissue cells leading to apoptosis and thus promoting the 
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spread of the infection (Freer and others 1968).  Alpha-toxin is also capable of 
killing platelets, red blood cells and immune cells resulting in a decreased 
immune response (Bhakdi and Tranum-Jensen 1991; Freeman-Cook and 
Freeman-Cook 2006). 
Carriage 
 Staphylococcus aureus is fairly ubiquitous in nature and can be found in 
water, raw milk, air, decaying vegetation and sewage, though the mucous 
membranes and skin of mammals, including humans, are its primary reservoir 
(Freeman-Cook and Freeman-Cook 2006; Bergdoll 1989).    The skin of most 
healthy humans is colonized by S. aureus, though they don’t usually become 
infected because the epidermis serves as a barrier through which the bacteria 
can not pass into the body.  However, if the bacteria are given an entry point via 
an injury or surgical site, it can lead to an infection (Freeman-Cook and Freeman-
Cook 2006).  Of the possible skin colonization sites, rectal carriage seems to be 
the most significant because it may lead to colonization of the G.I. tract.  
Aditionally, research has shown that people who carry S. aureus in both the 
nasal and rectal regions are more likely to develop an infection than those who 
only exhibit nasal carriage (Squier and others 2002).  It is important to note that 
while all skin carriers are not necessarily nasal carriers; nasal carriers are more 
likely to carry S. aureus at other body sites such as the hands and the perineum 
(Polakoff and others 1967).   
 While S. aureus lives on the skin of many humans, colonization of the 
mucous membranes is usually of greater concern.  The nasal membranes of 
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humans provide an ideal colonization site for S. aureus because they are damp 
and in the optimum temperature range of the pathogen (Freeman-Cook and 
Freeman-Cook 2006).  It is important to note that though the nasal membranes 
are the most common carriage site of S. aureus for humans, reported carriage 
frequencies may vary depending on which part of the nasal mucosa is tested 
(Williams 1963).   
 By the early 1960’s researchers had identified three general nasal 
carriage patterns among humans.  Nearly 60% of the population displays a 
sporadic carriage of S. aureus where the individual strain may vary over time; 
these people are referred to as intermittent carriers.  Roughly another 20% of the 
population are constantly carrying a single strain of the pathogen and are 
commonly referred to as persistent carriers.  Lastly, the remaining 20% of the 
population very rarely carry S. aureus and are thus referred to as non-carriers, 
though some members may carry the organism occasionally (Kluytmans and 
others 1997; Williams 1963).   
These carriage patterns can be further broken down by population 
demographics including gender, ethnicity, age and overall health.  A data study 
carried out at the Medical University of South Carolina found that men are more 
likely than women to harbor S. aureus; however, there are no gender-based 
carriage differences in infants (Mainous III and others 2006; Peacock and others 
2003).  Furthermore, the study indicated that people of Hispanic origin are more 
likely to be S. aureus carriers than non-Hispanic whites or non-Hispanic blacks 
(Mainous III and others 2006).  While still not proven, some researchers believe 
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that this carriage pattern may be due to some sort of genetic influence (Peacock 
and others 2001).  
Early research into the carriage rates of young children found that in one 
hospital maternity ward nearly 100% of the newborn infants were nasally positive 
for S. aureus within one week of birth.  However, after six months of age the 
carriage rates declined steadily until six years of age where typical population 
rates were observed (Cunliffe 1949; Williams 1963).  Furthermore, carriage rates 
begin to increase again during adulthood (Williams 1963; Mainous III and others 
2006).  It has also been shown that the elderly, adults over 65, are less likely to 
carry the microorganism; though when they do, it is likely to be a more 
pathogenic strain (Mainous III and others 2006).  Miller and his associates 
theorized that the carriage rate increases after adolescence due to increased 
contact with children and is then reduced with older age because of a decrease 
in that contact (1962). 
Lastly, carriage rates of Staphylococcus aureus can be affected by the 
overall health of the population.  Research has shown that cigarette smoking, 
exposure to cigarette smoke and use of antibiotics do not increase the risk of 
carriage. However, people who suffer from asthma have significantly higher 
carriage rates than those who do not, though the reason is still unclear (Mainous 
III and others 2006).  Similarly, HIV-positive people or those suffering from 
chronic diseases such as AIDS have increased carriage rates, probably due to 
decreased immune function though the reason is still unclear because of the 
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extensive use of antibiotics in these demographic groups (Kluytmans and others 
1997).   
Transmission 
 In addition to being responsible for severe infections such as pneumonia, 
meningitis, septic arthritis and blood infections, S. aureus is also the leading 
cause of surgical wound infections in the United States (Freeman-Cook and 
Freeman-Cook 2006).  It has been estimated that nearly 20% of all surgical 
patients will acquire an infection during recovery; thus making S. aureus an 
important cause of illness and death in hospital patients (Wertheim and others 
2005; Ahmed and others 1998).  Most researchers believed that post-operative 
staphylococcal infections were due to cross-colonization from other hospital 
patients, but early work carried out by Kluytmans and his associates identified 
nasal carriage of the pathogen as a risk factor in the development of infections 
and attributed many of the infections to bacteria all ready colonizing the patient 
(1995).  
 When comparing the strains of S. aureus found in the blood of hospital 
patients suffering from bacteremia to those found in the patient’s nasal cavities, 
researchers found that nasal isolates were responsible for the blood infections in 
nearly 80% of the cases, establishing that the majority of S. aureus infections are 
of host origin (von Eiff and others 2001).  Further research carried out by 
Wertheim and his colleagues found that nasal carriers of S. aureus displayed an 
increased risk of developing nosocomial staphylococcal bacteremia, but that non-
carriers were more likely to die from the disease.  They attributed this finding to 
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an immunological adaptation by the carriers to their endogenous strains (2004).  
Wenzel and Perl theorize that the pathogen is carried from the nose to other 
body areas where infection is likely to occur such as surgical sites and skin 
wounds via the hands; if this theory is correct, it may also account for the 
presence of S. aureus on the hands of nasal carriers as described by Polkaloff 
and her associates (1995; 1967). 
 Not only does the presence of S. aureus in the nasal cavities of a patient 
increase the likelihood of a post-operative infection, but the amount being carried 
is a factor as well.  A study carried out at the University of Louisville found that 
patients harboring large quantities of the pathogen, referred to as heavy carriers, 
had an increased chance of developing a post-operative infection when 
compared to non-carriers or people carrying lower numbers of the bacteria 
(White 1963).  
 In order to prevent infection from endogenous strains of S. aureus, 
researchers have suggested the elimination of nasal carriage prior to 
hospitalization or surgery (Kluytmans and Wertheim 2004).    Most of the work 
conducted in this area has focused on the use of mupirocin to eradicate the 
organism from colonized individuals.   A study conducted by the University 
Hospitals of Geneva compared the efficacy of intranasal treatment of colonized 
individuals with mupirocin to that of individuals treated with placebo and found 
that, while nasal carriage rates were lowered in some patients, there was no 
associated reduction in the carriage rates of other body areas (Harbarth and 
others 1999).   
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A later study investigated the effects of preoperative administration of 
mupirocin on the rates of operation site infections after surgery.  Patients were 
treated with mupirocin intranasally for 5 days before surgery and were monitored 
for the presence of any S. aureus infections for one month postoperatively.  
Researchers were able to eradicate nasal carriage of the pathogen in 83.4% of 
the patients receiving the antibiotic; however, they observed no appreciable 
difference in infection rate between the treatment and placebo groups though the 
treatment was able to lower the number of nosocomial infections among the 
colonized patients (Perl and others 2002).  Thus, the prophylactic use of 
mupirocin may be beneficial in the elimination of nosocomial infections in post-
operative hospital wards (Kluytmans and Wertheim 2004).  
While nosocomial or hospital acquired infections involving S. aureus can 
come directly from other patients, a large number of patients acquire the infection 
from hospital workers who carry their own endogenous bacteria on their hands or 
transfer the pathogen from other colonized patients in the hospital (Lowy 1998).  
This method of transfer is evidenced by the fact that not all patients who acquire 
a staphylococcal infection are carriers of the bacteria.  A study conducted in the 
Netherlands looked at the S. aureus carriage rates of healthcare workers and 
found that 35% are colonized with the pathogen (Ballemans and others 1999).  In 
order to control the number of nosocomial infections due to transient carriage of 
the organism by healthcare workers, many researchers have recommended that 
hospitals institute cleanliness measures that require employees to wear masks 
and follow rigorous hand hygiene protocols (Lacey and others 2001; Pittet 2001).  
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A hospital in the Netherlands has even gone as far as to prohibit colonized 
employees from going to work until they can be treated and cleared of the 
organism (Blok and others 2003). 
Another method of S. aureus transfer that is becoming increasingly more 
common is the transfer from pets to people and vice versa.  One of the first 
cases of this phenomenon occurred at Wrexham Maelor Hospital where 
screening of staff for the pathogen revealed a nurse to be colonized with the 
organism.  After treatment, the nurse continued to test positive for S. aureus 
leading him to suspect his dog with which he shared a home.  Nasal swabs from 
the dog tested positive for the same strain carried by the nurse, indicating that 
the dog was the reservoir of the pathogen in the home (Cefai and others 1994).  
A 2005 study looking at the staphylococcal carriage rates of veterinary personnel 
and dogs in a small animal clinic found that 9% of dogs may carry methicillin-
resistant S. aureus, demonstrating the potential for cross-colonization between 
pets and people (Loeffler and others 2005).  Lastly, Weese and his associates 
reviewed several cases where staphylococci were transmitted between pets and 
their owners and found that in some cases, the pets actually acquire the bacteria 
from their owners who typically work in hospital environments (2006). 
Staphylococcal Enterotoxins 
 The staphylococcal enterotoxins are a group of globular proteins, 
produced by the bacterial cell during growth, with molecular weights ranging from 
28,000 to 35,000 daltons (Halpin-Dohnalek and Marth1989).  The molecules are 
single-chained, charged and incorporate large amounts of aspartic acid, 
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threonine and serine which account for roughly 30% of their amino acid content 
(Johnson and others 1991).  The enterotoxins are heat stable, water and saline 
soluble; they exhibit emetic properties and are resistant to digestion by 
proteolytic enzymes (Thomas and others 2007, Honeyman and others 2001).   
Heat resistance of the enterotoxins is an especially important food safety 
consideration (Balaban and Rasooly 2000).  Early research showed that 
staphylococcal enterotoxins are able to survive the milk pasteurization process 
even at low initial concentrations (Tatini 1976).  Similarly, a study conducted by 
Schantz and his colleagues found that enterotoxin B is able to retain activity after 
being heated to 60º C for up to 16 hours (1965).    Even if enterotoxins are 
inactivated by a severe thermal process the result may only be temporary as 
research has shown that many of the enterotoxins possess the ability to 
reactivate making it nearly impossible to eliminate them once they’re been 
formed (Fung and others 1973). 
Extracellular Factors 
 There are a variety of outside factors such as pH, temperature, 
atmospheric makeup, and salt concentration that can affect the production of 
enterotoxins by S. aureus (Halpin-Dohnalek and Marth 1989).  As stated earlier, 
S. aureus is able to grow at a wide pH range; however, enterotoxin production 
requires a more specific range.  The staphylococcal enterotoxins are produced 
optimally at a pH range of 6.44 to 7.20, though research has shown some 
serotypes are produced at a pH as low as 4.5 and as high as 9.02 under certain 
conditions (Halpin-Dohnalek and Marth 1989; Scheusner and others 1973; Tatini 
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and others 1971).  Temperature is also correlated with pH as optimal growth 
temperatures can counteract the effects of an undesirable pH (Halpin-Dohnalek 
and Marth 1989).  The ideal temperature for growth of S. aureus is 37º C, though 
enterotoxins can be produced over a temperature range of 10 to 46º C with 
maximum production occurring between 40 and 45º C (Halpin-Dohnalek and 
Marth 1989; Tatini 1973). 
 Because S. aureus is a facultative anaerobe, it is able to grow in the 
absence of oxygen; however, enterotoxin production is quite limited under 
anaerobic conditions (Baird-Parker 1971).  Jarvis and his associates observed 
the production of staphylococcal enterotoxins by S. aureus in baffled and non-
baffled flasks where baffling was said to create greater aeration in the culture 
medium.  They found that more enterotoxin was generally produced in the 
aerated flasks; furthermore, some strains produced nearly twice as much 
enterotoxin in the oxygen-rich environment (1973).  However, research 
conducted by Marland demonstrated that enterotoxin production could actually 
be reduced in environments where oxygen levels were too high, though S. 
aureus was still able to grow (1967).   
 As stated earlier, S. aureus is able to grow readily in media containing 5% 
salt while some strains are able to survive in the presence of 10 to 15% salt; 
however, the salt concentration at which enterotoxins can be produced is 
dependent upon the pH (Minor and Marth 1976; Genigeorgis and Sadler 1966).  
In their study, enterotoxin was produced by S. aureus in media containing 8% 
NaCl at a pH of 5.5 but was only able to be produced up to a salt concentration 
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of 4% at a pH of 5.1.  Similarly, enterotoxin was produced in media containing 
10% salt at a pH of 6.9; thus, they concluded that enterotoxin production in the 
presence of NaCl is optimized at a less acidic pH (Genigeorgis and Sadler 1966).  
Thus, the production of enterotoxin in foods can be somewhat controlled by salt 
concentration and pH of the product.   
Classification 
 The staphylococcal enterotoxins are strain specific; however, each strain 
has the ability to produce more than one serotype of the toxin (Halpin-Dohnalek 
and Marth 1989).  There are several enterotoxins, currently designated as 
staphylococcal enterotoxins A through E and G through J along with a number of 
staphylococcal enterotoxin-like compounds that are closely related but lack 
emetic properties (Honeyman and others 2001; Thomas and others 2007).  
Staphylococcal enterotoxin C is further divided into 3 subtypes: C1, C2 and C3 
(Bennet 2001).  The enterotoxins produced by S. aureus exhibit a high degree of 
homology in their amino acid sequences which has led researchers to suggest 
that the different enterotoxins are the result of gene duplication from an ancestral 
toxin-like compound (Iandolo 1989).  The homology can range between 30 and 
86% with all serotypes displaying similar biological roles (Betley and Mekalanos 
1988; Johnson and others 1991).  This homology has also enabled the 
categorization of the enterotoxins into three groups based on their genetic 
relationships.  Group 1 contains staphylococcal enterotoxins A, D, E, H and J; 
while group 2 contains enterotoxins B, C and G.  Staphylococcal enterotoxin I is 
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the only true enterotoxin in group 3 which also contains several enterotoxin-like 
substances (Thomas and others 2007).  
 Of the staphylococcal enterotoxins, enterotoxin A is considered to be the 
most toxic and is most often responsible for staphylococcal food poisoning 
(Huang and others 1987; Holmberg and Blake 1984).  Researchers suggest that 
enterotoxin A is more prevalent in staphylococcal food poisoning because it is 
the most common type carried by humans (Casman 1965).  Enterotoxin D is also 
commonly incriminated in outbreaks of staphylococcal foodborne illness, followed 
by enterotoxin B which can be implicated in 10% of cases (Jarvis and others 
1973; Casman 1965).  Similarly, strains of S. aureus that produce staphylococcal 
enterotoxin B are most often associated with nosocomial infections, indicating 
that it may be more successful in enabling tissue invasion than the other 
enterotoxins (Halpin-Dohnalek and Marth 1989).   
Foodborne Intoxication 
 Staphylococcal food poisoning is one of the most common types of 
foodborne illness based on the number of outbreaks and cases that are reported 
annually; coming in third behind food borne illnesses due to Salmonella and 
Clostridium perfringens (Atanassova and others 2001). However, most isolated 
cases of staphylococcal intoxication go unreported, indicating that the disease 
may be more prevalent than statistics imply (Genigeorgis 1989; Tranter 1990).  
The primary cause of staphylococcal food poisoning is contamination of foods by 
carriers of enterotoxigenic S. aureus which then grow in the food and produce 
enterotoxin (Bania and others 2006).  The bacteria can be introduced into food 
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when it comes into contact with the hands of infected workers or when nasal 
carriers cough or sneeze on the food (Bennet 2001).  Once the bacteria has 
incubated in the food for anywhere from 30 minutes to 8 hours, depending on 
temperature, it will have produced enough toxin to make a consumer ill 
(Holmburg and Blake 1984).  A person can experience symptoms after ingesting 
only 1 microgram of the preformed toxin: an amount that is produced once the 
bacterial population surpasses 105 per gram of contaminated food (International 
Medical Publishing 2004).  In very sensitive people, symptoms may be induced 
by as little as 100 to 200 ng of toxin (Bennett 2001). 
 Once the food containing preformed enterotoxin has been ingested, the 
consumer will usually begin to experience symptoms within 2 to 6 hours (Balaban 
and Rasooly 2000).  The exact mechanism by which staphylococcal enterotoxins 
induce illness is still unknown, but researchers theorize that they bind to “emesis 
receptors” in the GI tract to induce vomiting, thus freeing the bacteria from the 
acidic digestive system (Freeman-Cook and Freeman-Cook 2006).  Symptoms of 
intoxication include nausea, vomiting, stomach cramps, diarrhea and fatigue 
(Freeman-Cook and Freeman-Cook 2006; International Medical Publishing 
2004).  People affected by the illness will usually recover within 1 to 3 days 
without medical intervention and the intoxication is rarely fatal; though the elderly 
have displayed increased rates of illness and death (Tranter 1990; Balaban and 
Rasooly 2000).  
 Any food or food product that has the appropriate pH and salt 
concentration and is held at the right temperature can serve as a medium for 
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enterotoxigenic S. aureus to grow and produce enterotoxin (Halpin-Dohnalek and 
Marth 1989).  Foods that have been implicated in staphylococcal intoxication 
outbreaks include milk products, meat and poultry, eggs products, salads, 
sandwiches and sandwich fillings, cream-filled bakery products such as pastries, 
pies and éclairs; as well as foods that require hands-on preparation and those 
that are held above refrigeration temperatures after preparation (Bennett 2001).  
The foods that are implicated in outbreaks differ depending on the country in 
which the outbreak occurs.  For example staphylococcal intoxication outbreaks in 
the UK are typically due to meat products such as ham; outbreaks in France are 
most often due to milk products; in the United States the culprit is usually red 
meat (Le Loir and others 2003).    
 Staphylococcus aureus is quite ubiquitous in nature and so cannot be 
eliminated from the people who prepare food.  However, researchers have made 
suggestions to aid consumers and food service establishments in avoiding 
outbreaks of staphylococcal intoxication:  foods should be held at or below 10º C, 
or above 45º C to prevent excessive growth of the pathogen.  They also suggest 
that refrigerated foods be packaged into small portions to ease quick cooling of 
the food product (Bennett 2001).  
  Genetic Control of Enterotoxin Production 
 Each staphylococcal enterotoxin is encoded by an individual gene within 
the bacterial DNA; however, strains of S. aureus typically carry more than one of 
these enterotoxin genes and are thus able to produce multiple serotypes of the 
toxin (Halpin-Dohnalek and Marth 1989).   
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 The staphylococcal enterotoxin A gene, entA, consists of approximately 
770 base pairs and encodes for a 257 amino acid protein precursor which 
includes a 24 amino acid signaling sequence.  This sequence is cleaved after 
translation resulting in an active protein containing 233 amino acids (Betley and 
Mekalanos 1988).  The entA gene differs from the genes encoding the other 
staphylococcal enterotoxins in a few important ways.  The gene encoding 
enterotoxin A is carried by a bacteriophage that is integrated into the bacterial 
chromosome as opposed to being naturally present like some other 
staphylococcal enterotoxin genes (Betley and Mekalanos 1985; Balaban and 
Rasooly 2000).  Another special characteristic of the entA gene is that, unlike the 
other enterotoxin genes, it is not regulated by the accessory gene regulator or 
agr.  Researchers believe that this lack of agr regulation may be responsible for 
the prevalence of enterotoxin A in foodborne intoxications involving S. aureus 
(Tremaine and others 1993).    
  The entB gene is composed of roughly 900 nucleotides that encode for 
an enterotoxin B precursor protein consisting of 267 amino acid residues 
including a 27 residue membrane-bound signaling sequence; thus, the active 
protein contains 240 amino acids (Johns and Khan 1988; Tweten and Iandolo 
1981).  Research has shown that entB can be chromosomally located in S. 
aureus as well as being carried by a plasmid.  Early work conducted by Shalita 
and others found that enterotoxin B production in S. aureus can be encoded by a 
plasmid that also carries genes for resistance to methicillin and tetracycline 
(1977).  However, further research carried out at Kansas State University found 
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that the entB gene is located on the actual bacterial chromosome in strains of S. 
aureus isolated from foods involved in outbreaks of staphylococcal intoxication 
(Shafer and Iandolo 1978).   
The 3 subtypes of staphylococcal enterotoxin C: SEC1, SEC2, and SEC3 
are antigenically different but exhibit considerable cross-reactivity (Balaban and 
Rasooly 2000; Bergdoll and others 1965).  The staphylococcal enterotoxin C3 
gene, entC3, consists of about 800 base pairs and encodes for a precursor 
protein containing 266 amino acids, 27 of which serve as a signaling sequence.  
The mature SEC3 protein contains 239 amino acids (Hovde and others 1990).  
When researchers aligned the nucleotide sequences of the 3 SEC genes, they 
found that not only did each gene contain 801 base pairs, but they demonstrated 
substantial homology as well.  When mature, SEC2 and SEC3 proteins only differ 
by 4 amino acids; similarly, SEC1 differs from SEC2 by 7 amino acids and from 
SEC3 by 9 (Hovde and others 1990).  This extensive similarity is most likely 
responsible for the cross-reactivity of the enterotoxin C subtypes. 
 The gene encoding for staphylococcal enterotoxin D, entD, is located on a 
plasmid that also encodes for production of staphylococcal enterotoxin J and the 
enzyme penicillinase, which confers the bacterium with resistance to the 
antibiotic penicillin.  The gene consists of 774 nucleotides that encode for a 
protein containing 258 amino acids, 30 of which make up the signaling peptide 
(Bayles and Iandolo 1989).    
 The gene, entE, encoding for production of staphylococcal enterotoxin E, 
is made up of 774 base pairs that encode for a protein precursor with 257 amino 
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acids; once processed, the active extracellular protein contains 230 amino acids.  
Staphylococcal enterotoxin E is very closely related to enterotoxin A.  When the 
nucleotide sequences of the entA and entE genes were compared, an 84% 
sequences homology was observed. Comparison of the amino acid sequences of 
the 2 genes also indicated a close genetic relationship (Couch and others 1988). 
 Staphylococcal enterotoxin G is encoded by the entG gene which consists 
of 774 base pairs that are processed to form a protein precursor made up of 258 
amino acids.  Once the signaling sequence has been cleaved, the active protein 
contains 233 amino acids.  Nucleotide sequence comparison has shown 
staphylococcal enterotoxin G to be genetically similar to both SEB and SEC, as 
well as an enterotoxin produced by some species of Streptococcus; 
streptococcal pyrogenic enterotoxin A or SpeA (Munson and others 1998).  
 The staphylococcal enterotoxin H gene, entH, contains 725 nucleotides 
that encode for a precursor protein that is 241 amino acid residues long, 24 of 
which comprise the signaling sequence; thus, the active protein contains 217 
amino acids.  Comparison of the SEH protein sequence to those of other 
staphylococcal enterotoxins revealed that enterotoxin H is most closely related to 
SEA, SED, and SEB where homologies of 37%, 33%, and 27% respectively were 
observed (Ren and others 1994).  Because SEH displays relatively low homology 
to other staphylococcal enterotoxins, it is theorized that it may be a more distant 
enterotoxin (Balaban and Rasooly 2000).   
 Staphylococcal enterotoxin I is encoded by the entI gene which consists of 
726 base pairs that encode for a precursor protein containing 242 amino acids 
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including a 24 residue signaling sequence.  The active protein contains 218 
amino acids (Munson and others 1998; Balaban and Rasooly 2000).  When 
nucleotide and protein sequences are compared, staphylococcal enterotoxin I 
has the lowest homology to other enterotoxins (Balaban and Rasooly 2000).  
Research has shown SEI to be structurally different from other enterotoxins in 
that it is vulnerable to damaging enzymes such as proteases.  Similarly, the 
protein is less stable and must be ingested in higher doses to elicit an emetic 
reaction (Munson and others 1998). 
 As stated earlier, the plasmid that carries the entD gene also carries the 
staphylococcal enterotoxin J gene, entJ.  The entJ gene encodes for a precursor 
protein containing 269 amino acids that, when aligned, exhibits a 64-66% 
homology to the SED protein.  The 2 genes are separated by 895 nucleotides 
and are oriented as to be read in opposite directions on the plasmid.  Further 
research utilizing PCR amplification indicates that the staphylococcal J gene is 
present on all plasmids that encode for the production of SED (Zhang and others 
1998).  
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OBJECTIVE OF PRESENT STUDY 
 
 Vegetative cells of S. aureus are easily killed by most heat treatments 
currently being utilized in the food industry, including pasteurization.  However, 
staphylococcal enterotoxins are able to survive these thermal processes and 
remain in the food where they pose a serious threat of illness to consumers.  
While the serotype of the staphylococcal enterotoxin present in an intoxicated 
food can be easily deduced using various laboratory testing kits, at the current 
time there are no means by which to trace the enterotoxin to the specific strain of 
Staphylococcus aureus by which it was produced.  
 The purpose of this research study is to examine enterotoxigenic strains of 
S. aureus for variations in the nucleotide sequence of the enterotoxin gene and 
the amino acid sequence of the enterotoxin using staphylococcal enterotoxin A 
as a model.  Our hope is that any observed differences will allow for a strain-level 
identification of the strain of S. aureus that produced the toxin.  This methodology 
could then be applied to all enterotoxin serotypes produced by strains of S. 
aureus resulting in the development of a database that would facilitate the 
identification of a specific strain of Staphylococcus based on the nucleotide 
sequence of its enterotoxin. 
 The development of such a database would not only be beneficial to food 
manufacturers in locating the possible sources of staphylococcal contamination, 
but could also be employed in the event that staphylococcal enterotoxin is 
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 Staphylococcal enterotoxin is a common cause of foodborne intoxication 
and has recently been designated as a select agent.  Staphylococcal 
enterotoxins are tolerant of heat and can often be found in foods that have 
undergone thermal processes severe enough to kill the vegetative cells of the 
organism.  Currently, there is no method available to trace a staphylococcal 
enterotoxin to its biological source.     
 Two sets of primers were developed to amplify the entA gene of several 
isolates of Staphylococcus aureus using PCR.  The PCR products were then 
compared to look for variations in the nucleotide sequences among the strains of 
S. aureus.  The DNA sequences were also translated into proteins which were 
compared to see if any variations in their amino acid sequences could be 
observed. 
  Variations were observed in both the nucleotide and amino acid 
sequences of many of the isolates of S. aureus.  However, a few isolates 
exhibited identical nucleotide and amino acid sequences.  In these cases, the 
PCR products were of differing lengths; thus, there could have been sequence 
variations outside of the amplified region of the gene.   
 This study indicates that it may be possible to identify a strain of S. aureus 
based on the nucleotide or amino acid sequence of its enterotoxin.  Further 
research is required to determine if this method is applicable to serotypes of 






Staphylococcus aureus is a pathogenic microorganism that is commonly 
responsible for nosocomial infections and foodborne intoxication in humans 
(Freeman-Cook and Freeman-Cook 2006).  Staphylococcal intoxication is the 
third most common form of foodborne illness, surpassed only by the occurrence 
of Salmonella and Clostridium perfringens infections (Atanassova and others 
2001).  Food is typically contaminated with the bacterium by food preparers who 
carry enterotoxigenic S. aureus in their nasal passages and transfer it to the food 
via their hands or sneezing (Bania and others 2006; Bennet 2001).  A 2007 CDC 
report estimates that nearly 32% of Americans carry the microbe (CDC 2007).  
Foodborne staphylococcal intoxication occurs when food, containing the pre-
formed enterotoxins produced by S. aureus, is consumed. 
 The staphylococcal enterotoxins are a group of proteins produced by the 
organism that induce an emetic response in humans along with other 
gastrointestinal symptoms (Freeman-Cook and Freeman-Cook 2006).  While S. 
aureus is able to produce several enterotoxin serotypes, enterotoxin A is the 
most common type to be associated with foodborne illness; probably because it 
is also the most common serotype carried by humans (Holmberg and Blake 
1984; Casman 1965).   
The presence of staphylococcal enterotoxins is especially important in 
food safety because they are very resistant to heat (Balaban and Rasooly 2000).  
The enterotoxins produced by S. aureus have been shown to maintain their 
activity through thermal processes such as milk pasteurization, and enterotoxin B 
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is able to stay active after being held at 60ºC for several hours (Tatini 1976; 
Schantz and others 1965).  Many of the thermal processes used in foods are 
severe enough to kill any vegetative cells of S. aureus, leaving only the toxin 
behind.   
In addition to food safety concerns, the staphylococcal enterotoxins have 
recently been added to HHS and USDA Select Agents and Toxins list because of 
their ability to act as superantigens (CDC 2006; Ulrich and others 2007).  While 
there are several ways to detect staphylococcal enterotoxin in foods, there are 
not currently any methods by which the enterotoxin can be traced back to the 
strain of S. aureus that produced it.  
The objective of the present study was to examine the nucleotide 
sequence of the enterotoxin gene and the amino acid sequence of the actual 
enterotoxin produced by various strains of S. aureus for variations using 
enterotoxin A as a model.  If successful, this methodology could be utilized in 
building a database that would allow for the identification of a specific strain of S. 
aureus based on the nucleotide sequence of its enterotoxin.  Such a database 
could not only be used by food manufacturers in establishing the source of 
staphylococcal contamination, but would also be forensically beneficial to 
investigators if staphylococcal enterotoxin were ever purposely introduced into 




MATERIALS AND METHODS 
 
 
Isolation and Identification of Staphylococcus aureus 
 Nine commercial strains of Staphylococcus aureus were purchased from 
American Type Culture Collection (ATCC).  These strains are:  S. aureus subsp 
aureus ATCC 14458, ATCC 8095, ATCC 51650, ATCC 51651, ATCC 13565, 
ATCC 13566, ATCC 27664, ATCC 19095, and ATCC 51740.  Additional strains 
were isolated from a variety of biological sources including raw milk, fecal 
samples from various animal species and human nasal swabs.   
 Isolation of S. aureus from milk was carried out using raw milk samples 
collected from local dairies.  Ten milliliters of milk was added to one-hundred 
milliliters of sterile Bacto Tryptic Soy Broth or TSB (BD, Sparks, MD, USA) and 
allowed to incubate at 37º C for 24 hours.  After incubation, a loop of enrichment 
culture was streaked for isolation on CHROMagar Staph aureus (CHROMagar 
Microbiology, Paris, France) and allowed to incubate at 37º C for 24 hours.  Two 
to three well-isolated typical (mauve-colored) colonies were picked, using a 
sterile disposable needle, into test tubes containing ten mL volumes of sterile 
TSB and incubated for 24 hours at 37º C prior to storage at refrigeration 
temperatures (2-5º C). 
 Fecal swabs were collected from chickens, ducks, pigs, cattle, a snake, a 
llama and a camel.  Also, swabs were collected from the intestines of a wild boar.  
Sterile swabs were used to collect the feces and/or intestinal contents and placed 
in tubes containing ten milliliters of TSB which were incubated at 37º C for 24 
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hours.  Presumptive S. aureus organisms were then isolated from the enrichment 
and stored as described above.  
 Nasal swabs were collected from various lab personnel and from people 
working with or around livestock.  A sterile swab was inserted into the nose as far 
as comfortably possible and rotated to ensure contact with nasal surfaces.  The 
swab was then placed in a test tube containing ten milliliters of TSB and allowed 
to incubate for 24 hours at 37º C.  The enrichment culture was then processed 
and stored as previously described.  All isolates were maintained by weekly 
subculturing in TSB using a 1% inoculum and incubation at 37º C for 18 to 24 
hours.  Cultures were subcultured for three consecutive days prior to being used 
in any experiments and were stored at refrigeration temperatures between uses. 
 Each isolate underwent a series of identification tests including Gram 
stain, the coagulase test, the catalase test, the hemolysis test and biochemical 
testing using the API Staph identification system (bioMérieux, Hazelwood, MO, 
USA).  
 Gram stains were performed on all isolates to help confirm purity and to 
observe the morphology and Gram reaction of the cells.  Isolates were then 
streaked onto Tryptic Soy Agar (TSA), TSB supplemented with 1.5% granulated 
agar (BD, Sparks, MD, USA), and incubated for 24 hours at 37º C.  To test for 
the presence of coagulase, several colonies from the TSA plates were picked 
into a tube containing 0.5 milliliters of reconstituted lyophilized rabbit plasma (BD, 
Sparks, MD, USA) and incubated in a 37º C waterbath for 4 hours.  Tubes were 
examined for the formation of a complete or partial clot which indicated the 
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presence of coagulase.  Following the removal of colonies for the coagulase test, 
TSA plates were flooded with 3% hydrogen peroxide where bubbling indicated 
the presence of the enzyme catalase.  To test for β-hemolysis, which is typical of 
S. aureus, isolates were streaked for isolation onto Blood Agar Plates containing 
5% sheep blood (BD, Sparks, MD, USA) and allowed to incubate for 48 hours at 
37º C.  Plates were observed for the formation of clear or transparent zones 
around the streak caused by lysis of the red blood cells in the medium. 
 Isolates that were found to be Gram positive cocci, tested positive for the 
production of both coagulase and catalase, and exhibited β-hemolysis were 
presumed to be S. aureus and subjected to identification testing.  Isolates were 
streaked onto Colombia Blood Agar (BD, Sparks, MD, USA) and allowed to 
incubate for 24 hours at 37º C.  Colonies were used to prepare a bacterial 
suspension in API Staph Medium (bioMérieux, Hazelwood, MO, USA) equal to a 
0.5 McFarland Standard.  This bacterial suspension was then used to inoculate 
the API Staph identification strips.  In accordance with manufacturer instructions, 
the ADH and URE cupules were filled with mineral oil to ensure an anaerobic 
environment; strips were then incubated at 37º C for 18-24 hours.  After 
incubation, results were developed in accordance with manufacturer instructions 
and recorded on the provided results sheets.  Identification of isolates was 
carried out using Bergey’s Manual of Systematic Bacteriology (Sneath and others 
1986) and apiweb® identification software (bioMérieux, Hazelwood, MO).  
Twenty-one isolates were determined to be S. aureus and were, along with the 
commercial strains, subjected to testing for enterotoxin production. 
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Enterotoxin Production 
   Production of staphylococcal enterotoxin types A, B, C, D and E by 
commercial and freshly isolated strains of S. aureus was detected using VIDAS® 
Staph Enterotoxin II test strips with the miniVIDAS system (bioMérieux, 
Hazelwood, MO, USA).  Isolates were subcultured 3 times prior to the 
experiment in TSB using a 1% inoculum and incubation at 37º C for 18 hours.  
Calibration of the miniVIDAS was performed using the standard and controls 
provided with the kit and the assay was carried out in accordance with 
manufacturer instructions.  
The test was carried out automatically by the miniVIDAS, and the results 
were analyzed mechanically by its computer.  The instrument calculated a test 
value for each isolate where a value equal to or above 0.13 indicated the 
presence of staphylococcal enterotoxin.  Isolates that tested positive for the 
production of staphylococcal enterotoxin were then subjected to enterotoxin 
typing. 
Enterotoxin Typing 
 Toxin typing was carried out using the Set-RPLA Toxin Detection Kit 
(Oxoid, Hampshire, UK) in accordance with manufacturer instructions.  The kit is 
capable of detecting staphylococcal enterotoxin types A, B, C and D.  Isolates 
were subcultured 3 times into TSB, using the previously detailed procedure, prior 
to use.  Cultures of S. aureus that produced staphylococcal enterotoxin A were 




 Isolates were subcultured in 10 milliliters of TSB (1% inoculum incubated 
at 37º C for 18-24 hours) 3 times prior to use.  Each fresh culture was centrifuged 
at 4000 rpm for 10 minutes; the supernatant was discarded and each cell pellet 
was resuspended in 500 µl of PBS.  The DNA was then extracted from the cells 
using the High Pure PCR Template Preparation Kit (Roche Applied Science, 
Indianapolis, IN, USA) in accordance with manufacturer instructions.  Extracted 
DNA was stored at -20º C for future use.   
16s rDNA Sequencing 
 The DNA extracted from each isolate was used to amplify, via PCR, a 
1500 base pair 16s rDNA fragment with BacT0008F 5’-
AGAGTTTGATCCTGGCTGAG-3’ and BacT1510R 5’-
GGTTACCTTGTTACGACTT-3’ primers using a MJ Dyad thermocycler (MJ 
Research, Waltham, MA).  The PCR reaction contained 25 µl that consisted of 16 
µl deionized water, 5 µl 5X buffer (Promega, Madison, WI, USA), 1.5 µl of 25 mM 
MgCl2 (Promega, Madison, WI, USA), 0.5 µl 10 mM dNTPs (Fisher Scientific, 
Pittsburgh, PA, USA), 0.5 µl 25 mM primers, 100 ng/µl BSA (Roche Applied 
Science, Indianapolis, IN, USA), 1.25 U Taq polymerase (Promega, Madison, WI, 
USA) and 1-2 µl template DNA.  The PCR cycling conditions were as follows: 4 
minutes at 95º C, followed by 35 cycles of 30 seconds at 95º C, 52º C for 30 
seconds and 1 minute and 45 seconds at 72º C; the reaction was then held at 4º 
C until removed.  To ensure the quality of the DNA, the PCR product was 
evaluated using gel electrophoresis with a 1.2% agarose gel where 10 µl of PCR 
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product was mixed with 2 µl of 6X loading dye and evaluated against a 1 Kb DNA 
ladder (Invitrogen, Carlsbad, CA, USA).  
 After the initial PCR reaction, samples underwent a DNA clean-up step 
prior to the sequencing reaction.  In a new PCR tube, 10 µl of PCR product was 
mixed with 2 µl of a shrimp alkaline phosphatase and exonuclease (USB Corp, 
Cleveland, OH, USA) mixture and put through a thermal cycle consisting of 30 
minutes at 37º C followed by 15 minutes at 85º C.  The PCR product resulting 
from this DNA clean-up process was then used in the sequencing reaction.   
 In the 16s rDNA sequencing reaction, 3 primers were used: BacT0008F, 
BacT1510R and BacT0805R 5’-GGACTACCAGGGTATCTAATCC-3’.  A master 
mix was prepared for each primer consisting of 4 µl deionized water, 1 µl 5X 
sequencing buffer (Applied Biosystems, Foster City, CA, USA), 1 µl 25 mM 
individual primer, 2 µl Big Dye (Applied Biosystems, Foster City, CA, USA) and 2 
µl PCR product from each sample.  The samples underwent thermal cycling 
conditions as follows: 2 minutes at 96º C, followed by 61 cycles of 30 seconds at 
96º C, 30 seconds at 50º C and 2 minutes at 60º C.  Prior to sequencing, ethanol 
precipitation of the DNA was performed. Twelve microliters of deionized water, 5 
µl 3M ammonium acetate and 57 µl of 100% ethanol were added to each tube 
and mixed before centrifugation at 4000 rpm for 30 minutes.  After discarding the 
supernatant, 70 µl of 70% ethanol was added to each tube, and they were once 
again centrifuged at 4000 rpm for 15 minutes.  The supernatant was discarded, 
and 10 µl of deionized water was added to the sample which was vortexed to 
bring the DNA into solution.  The DNA was sequenced by the Oklahoma State 
 45
University Recombinant DNA/Protein Core facility using an ABI Model 3730 DNA 
Analyzer (Applied Biosystems, Foster City, CA, USA).   
EntA DNA Sequencing 
 Using entA sequences from the National Center for Biotechnology (NCBI) 
database and a primer-building program, PrimerQuest (Available from: 
www.idtdna.com/Scitools/Applications/Primerquest), two sets of primers for the 
entA gene were developed:  primer set 1 consised of S. aureus Forward 1 5’-
CATTGCCCTAACGTGGACAACAAG-3’ and S. aureus Reverse 1 5’-
GCCACCATCTATCCAACTTGCTCA-3’, while primer set 2 consisted of S. 
aureus Forward 2 5’-AGGTGTCATTTGCTAATCCAACTG-3’ and S. aureus 
Reverse 2 5’-ACCTCATGACCATACTCACCA-3’.  The DNA extracted from all 
samples was PCR amplified separately with each primer set using a reaction that 
contained 14.75 µl deionized water, 2 µl 10X PCR Buffer (Roche Applied 
Science, Indianapolis, IN, USA), 1.2 µl 25 mM MgCl2 (Roche Applied Science, 
Indianapolis, IN, USA), 0.4 µl 25 mM primers, 0.4 µl 10 mM dNTPs, 1.25 U Taq 
polymerase and 2 µl of template DNA.  Cycling conditions consisted of: 2 
minutes at 94º C, followed by 34 cycles of 30 seconds at 94º C, 30 seconds at 
60º C and 72º C for 1 minute and 30 seconds; the reaction was held at 4º C until 
it was removed.  Quality of the PCR product was assessed using gel 
electrophoresis as previously described.  
 After the initial PCR, samples underwent the DNA clean-up process 
previously described followed by a PCR sequencing reaction.  The same master 
mix was used as with the 16s rDNA sequencing reaction.  Cycling conditions 
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consisted of 30 seconds at 95º C, followed by 61 cycles of 10 seconds at 96º C, 
10 seconds at 50º C and 1 minute at 60º C.  The DNA underwent ethanol 
precipitation and sequencing as previously described. 
Analysis of Results 
 The DNA sequences were aligned and analyzed using MEGA 4: 
Molecular Evolutionary Genetics Analysis software (Available at: 
www.megasoftware.net).  Phylogenetic trees were created using the MEGA 
neighbor-joining method with the p-distance matrix.  Bootstrapping was 
employed to assess the accuracy of the phylogenetic trees where a higher 
bootstrap value was indicative of a higher degree of accuracy.   
 The DNA sequences were translated into proteins using the Biology 
Workbench 6-frame translation function (Available at: workbench.sdsc.edu).  The 
longest open-reading frame was used to construct protein-based phylogenetic 
trees in MEGA using the parsimony method.  Once again, bootstrapping was 







Identification of Staphylococcus aureus 
 Isolates of S. aureus were identified based on Gram stain reactions, the 
coagulase test, the catalase test, the hemolysis test and the metabolism of 
various substrates using the API Staph identification system (Appendix A).   
 Metabolism patterns were based on the ability of the organism to 
metabolize the substrate in each cupule during incubation where metabolism of 
the substrate results in a visual color change.  Staphylococcus aureus is able to 
metabolize D-glucose, D-fructose, D-mannose, D-maltose, D-lactose, D-
trehalose, D-mannitol, D-saccharose, L-arginine and urea (Sneath and others 
1986).  Based on metabolism patterns and positive results for all other 
identification tests, all isolates were identified as S. aureus.  Isolates that match 
the metabolism patterns found in Bergey’s Manual of Systematic Bacteriology 
(Sneath and others 1986) are summarized in Table 1.  
Enterotoxin Production 
 Cultures of S. aureus were tested for their ability to produce 
staphylococcal enterotoxins A, B, C, D and E.  Using an assay based on the 
binding of staphylococcal enterotoxin in the culture medium to monoclonal anti-
staphylococcal enterotoxin antibodies.  The formation of this bond catalyzes the 
hydrolysis of a substrate resulting in the release of fluorescence that is measured 
at 450nm.  A relative fluorescence value (RFV) of 0.13 or above is indicative of a 
positive result for enterotoxin production by the isolate.   
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 All commercial strains of S. aureus tested positive for the production of 
enterotoxin; however, only 4 freshly isolated strains were shown to produce 
enterotoxin (Table 2).  The strains of S. aureus listed in this table were used for 
further study. 
Enterotoxin Typing 
 Isolates of S. aureus that produced enterotoxin were subjected to toxin 
typing using the Set-RPLA Toxin Detection Kit.  Identification of the enterotoxin 
subtype is based on the agglutination that occurs when antiserum purified with a 
staphylococcal enterotoxin A, B, C, or D comes into contact with its matching 
enterotoxin.  When agglutination occurs a lattice-like structure is formed that 
creates a visible layer that can be observed as a positive reaction.   
 Many of the isolates produced multiple enterotoxin subtypes (Table3).  
However, because foodborne staphylococcal intoxication is most commonly 
associated with enterotoxin A, only those isolates capable of producing SEA 
were chosen for use in further experiments (Holmburg and Blake 1984). Isolates 
shown to produce SEA include: S. aureus subsp aureus strains ATCC 13566, 
ATCC 13565, ATCC 51651, ATCC 19095, 27664, ATCC 8095, ATCC 14458 and 
PIG-M1.   
16s rDNA Sequencing 
 To ensure that all isolates were S. aureus, a 16s rDNA fragment from 
each isolate was amplified using PCR.  To make certain that the amplified DNA 
fragment was the correct size, 1500 base pairs, the PCR product was evaluated 
using gel electrophoresis.  The placement of the DNA fragments on the gel after 
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electrophoresis was then compared to a DNA ladder that allows the size of each 
DNA fragment to be discerned.  This process was repeated for all PCR products 
obtained throughout the study. 
    The PCR products from all isolates of S. aureus displayed the same DNA 
fragment size and, when compared to the 100 bp DNA ladder, were roughly 1500 
base pairs in size (Figure 1).  The PCR products were sequenced and the 
genetic relationships between the 16s rDNA nucleotide fragments from the 
isolates of S. aureus (Appendix B) were observed in the form of a phylogenetic 
tree (Figure 2).   
 The 16s rDNA fragments from the commercial isolates of S. aureus were 
shown to be very genetically similar while the laboratory isolate, S. aureus PIG-
M1, is slightly divergent.  The structure of the phylogenetic tree makes it appear 
as though S. aureus PIG-M1 is very different from the nucleotide sequences of 
the commercial strains; however, when the nucleotide sequences are aligned, 
there is only a 1-nucleotide substitution within the conserved region of the 
sequence.   
EntA DNA Sequencing 
 All isolates of S. aureus were subjected to PCR using 2 sets of primers: 
Primer Set 1 (SA1) and Primer Set 2 (SA2).  Amplification with SA1 resulted in a 
PCR product consisting of approximately 800 nucleotides while that resulting 
from amplification with SA2 consisted of roughly 500 nucleotides.  Primer Set 1 
amplified the entA gene of strains ATCC 13566, ATCC 13565, ATCC 51651, 
ATCC 19095, ATCC 27664, ATCC 8095 and PIG-M1.  In contrast, SA2 amplified 
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the entA gene of only 4 cultures:  strains ATCC 51651, ATCC 27664, ATCC 
14458 and PIG-M1.    
The PCR products were sequenced as previously described (Appendix C) 
and a dendogram was constructed from the results in order to observe the 
genetic relationships among the isolates (Figure 3).  The regions of the gene 
amplified by SA1 and SA2 are separate and do not overlap; thus, comparison of 
isolates is done separately for each primer set.  The nucleotide sequences of the 
entA genes amplified with SA1 from strains ATCC 13566 and ATCC 51651 were 
exactly the same and these sequences differed from those of strains ATCC 8095 
and ATCC 13565 by 9 nucleotides.  Similarly, the entA nucleotide sequence 
obtained by PCR amplification with SA1 from S. aureus PIG-M1 is identical to 
portions of both strain ATCC 27664 and strain ATCC 19095 amplified with the 
same primer set.  The nucleotide sequences of strains ATCC 8095 and ATCC 
13565 resulting from amplification with SA1 only differ by 1 nucleotide while 
those of strains ATCC 27664 and ATCC 19095 differ by 2 nucleotides.  With 
these exceptions, sequences obtained by amplification with SA1 differed from all 
other sequences by 100 nucleotides or more. 
The entA sequences obtained by amplification with SA2 were more 
divergent from each other than those obtained by amplification with SA1.  The 
SA2 amplified entA genes of strain PIG-M1 and strain ATCC 14458 only differed 
by 2 nucleotides. When all other SA2 amplified DNA sequences are compared, 
they differ by at least 14 nucleotides with some differing by as many 200 
nucleotides.  When the sequences obtained using SA2 are compared to those 
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obtained using SA1, there is an observable difference of at least 100 nucleotides 
for each comparison. 
In order to assess the similarity of the actual enterotoxin produced by each 
isolate, the entA DNA sequences were translated into proteins using the Biology 
Workbench 6-frame translation function.  The protein translation with the longest 
open reading frame for each isolate (Appendix D) was chosen to construct a 
phylogenetic tree using the MEGA parsimony method (Figure 4).   
 As expected, the PCR products from different isolates of S. aureus that 
showed identical nucleotide sequences also exhibited identical amino acid 
sequences.  This was the case for strains:  ATCC 13566 and ATCC 51651 
amplified with SA1, ATCC 19095 and PIG-M1 amplified with SA1, and ATCC 
27664 and PIG-M1 amplified with SA1.  Even though amplification with SA1 
showed a 2-nucleotide difference, the amino acid sequences of the PCR 
products from strains ATCC 27664 and ATCC 19095 were also identical, which 
can be attributed to the redundant nature of the genetic code.   
 The amino acid sequences of the proteins translated from the SA1 PCR 
products of strains ATCC 13566 and ATCC 51651 differed from strains ATCC 
13565 and ATCC 8095 by 3 amino acids.  Amplification with SA1 resulted in a 
difference of only 1 amino acid in the sequences of strains ATCC 13565 and 
ATCC 8095.  
 None of the proteins translated from the PCR products obtained by 
amplification with SA2 were identical.  Strains ATCC 27664 and ATCC 51651 
differed by 3 amino acids.  The amino acid sequence from strain ATCC 14458 
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differed from those of ATCC 27664 and PIG-M1 by 4 amino acid residues.  
Comparison of all other amino acid sequences resulted in at least 5, and often 





Foods associated with staphylococcal intoxication are typically those that 
require hands-on preparation which allows for contamination of the food by 
preparers carrying the microorganism.   These foods include milk and egg 
products, sandwich fillings, cream-filled pastries, salads, cheese, meats and 
poultry (Freeman-Cook and Freeman-Cook 2006; Bennet 2001).  Incubation of 
the organism in the food results in the production of enterotoxins that are harmful 
to the consumer (Holmburg and Blake 1984).   
Foods contaminated with S. aureus often undergo thermal processes at 
high enough temperatures to kill any vegetative cells of the organism.  The 
USDA recommends that hot foods be held at 60º C; however, vegetative cells of 
the bacterium are only able to survive at temperatures up to 50º C (USDA 2008; 
Baird-Parker 1965).  The absence of vegetative cells of S. aureus in 
contaminated foods poses a challenge to food manufacturers and investigators 
because, at the current time, there are no methods by which a staphylococcal 
enterotoxin can be traced to its vegetative source at the strain-level.  The ability 
to trace an enterotoxin to the specific strain of S. aureus that produced it would 
be especially important in the event that purified enterotoxin were introduced into 
the food supply as an act of bioterrorism.  
This study has shown that it may be possible to trace a staphylococcal 
enterotoxin to its vegetative source using only the nucleotide or amino acid 
sequence of the toxin.  There were observable differences among many of the 
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PCR products used in this study, indicating that the nucleotide and amino acid 
composition of staphylococcal enterotoxin A is somewhat variable.       
The entA gene of strains ATCC 51651 and ATCC 13566 amplified with 
SA1 were shown to have identical nucleotide and amino acid sequences. 
However, the length of the protein translations from these isolates differed by 
nearly 80 amino acids indicating that there may have been differences outside of 
the amplified region of the gene.  This is also the case for the PCR product 
obtained from amplification of S. aureus PIG-M1 with SA1.  The S. aureus PIG-
M1 PCR product was shown to be identical to those of strains ATCC 19095 and 
ATCC 27664; however, the sequence from strain PIG-M1 was more than 200 
nucleotides shorter.  The variable length of the PCR products could be easily 
overcome by developing and employing primers that allow the entire gene to be 
amplified.   
In order to build a staphylococcal enterotoxin database, all enterotoxin 
subtypes from all known strains of S. aureus would need to be processed in 
accordance with the methods described in this study.  This would require the 
development of primers for each subtype of enterotoxin and the PCR 
amplification of multiple genes from each bacterial strain.  
 In order to employ a staphylococcal enterotoxin database in determining 
the vegetative source of an enterotoxin, it would need to be extracted from the 
contaminated food product, purified and typed.  Once purified, the amino acid 
sequence of the enterotoxin would need to be determined.  The amino acid 
sequence of the enterotoxin in question would then be electronically compared to 
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the sequences all ready acquired using the methods described in this study.  In 
the event that the enterotoxin were purposely introduced into the food supply and 
a match were found in the database, investigators could survey culture 
companies who sell that specific strain of S. aureus to see who had recently 
purchased the culture, thus narrowing the field of suspects.       
Further research must be conducted to develop primers that allow for the 
amplification of the entire staphylococcal enterotoxin A gene, to develop similar 
primers for all enterotoxin subtypes and to ensure that observable variation does 
exist when the nucleotide and amino acid sequences of other enterotoxin 
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S. aureus  CHK-B3 S. aureus  MLK-1046
S. aureus  CHK-S2 S. aureus  MLK-1021
S. aureus  PIG-M1 S. aureus  MLK-1125
S. aureus  PIG-M2 S. aureus  MLK-1034
S. aureus PIG-M3 S. aureus  MLK-159
S. aureus  PIG-M4 S. aureus  JC
S. aureus  Camel S. aureus  SM
S. aureus  WB-2 S. aureus  JG
S. aureus  MLK-78 S. aureus  IT
S. aureus  MLK-182 S. aureus  JB
S. aureus  MLK-1041
TABLE 1
BASED ON METABOLISM PATTERNS1,2
ISOLATES DETERMINED TO BE STAPHYLOCOCCUS AUREUS
1All isolates were Gram (+), Coagulase (+), Catalase (+), β-hemolysis (+) coccus-
shaped bacteria
2Metabolism patterns compared to S. aureus as listed in Bergey's Manual of 









Strain A B C D
ATCC 14458 + + - -
ATCC 8095 + - - -
ATCC 51650 - - + -
ATCC 51651 + - - -
ATCC 13565 + - - +
ATCC 13566 + + - -
ATCC 27664 + - - -
ATCC 19095 + - + -
ATCC 51740 - - + +
PIG-M1 + - - -
MLK-159 - - - -
JG - - + -
JB - - - -
2Enterotoxin types determined using the SET-RPLA Staphylococcal
Enterotxoin Test Kit
1Enterotoxin production determined using the miniVIDAS and Staph
Enterotoxin II test strips
Enterotoxin Subtype
TABLE 2
ENTEROTOXIN TYPES PRODUCED BY CULTURES













7) S. aureus  subsp aureus  ATCC 8095, 8) S. aureus  subsp aureus  ATCC 14458,
9) S. aureus PIG-M1, 10) 100 bp DNA ladder
OF STAPHYLOCOCCUS AUREUS 1
1Lane Descriptions:  1) 100 bp DNA ladder, 2) S. aureus  subsp aureus  ATCC 13566,
3) S. aureus  subsp aureus  ATCC 13565, 4) S. aureus  subsp aureus  ATCC 51651,
FIGURE 1
GEL ELECTROPHORESIS OF 16s rDNA FRAGMENTS FROM
STAPHYLOCOCCAL ENTEROTOXIN A PRODUCING ISOLATES















PHYLOGENETIC ANALYSIS OF 16s rDNA NUCLEOTIDE SEQUENCES
FROM ISOLATES OF STAPHYLOCOCCUS AUREUS 1















PHYLOGENETIC ANALYSIS OF EntA NUCLEOTIDE SEQUENCES
FROM ISOLATES OF STAPHYLOCOCCUS AUREUS 1
FIGURE 3
1Tree constructed using the MEGA neighbor-joining method with the p-distance matrix.
S. aureus subsp aureus ATCC 13566 (SA1)
S. aureus subsp aureus ATCC 51651 (SA1)
S. aureus subsp aureus ATCC 13565 (SA1)
S. aureus subsp aureus ATCC 8095 (SA1)
S. aureus subsp aureus ATCC 27664 (SA1)
S. aureus subsp aureus ATCC 19095 (SA1)
S. aureus PIG-M1 (SA1)
S. aureus subsp aureus ATCC 27664 (SA2)
S. aureus subsp aureus ATCC 51651 (SA2)
S. aureus subsp aureus ATCC 14458 (SA2)






















PHYLOGENETIC ANALYSIS OF  ENTEROTOXIN A AMINO ACID 
1Tree constructed using the MEGA parsimony method.
SEQUENCES FROM ISOLATES OF STAPHYLOCOCCUS AUREUS1
S. aureus subsp aureus ATCC 13566 (SA1)
S. aureus subsp aureus ATCC 51651 (SA1)
S. aureus subsp aureus ATCC 8095 (SA1)
S. aureus subsp aureus ATCC 13565 (SA1)
S. aureus subsp aureus ATCC 19095 (SA1)
S. aureus subsp aureus ATCC 27664 (SA1)
S. aureus PIG-M1 (SA1)
S. aureus subsp aureus ATCC 51651 (SA2)
S. aureus subsp aureus ATCC 27664 (SA2)
S. aureus subsp aureus ATCC 14458 (SA2)































































Test Bergey1 CHK-B3 CHK-S2 PIG-M1 PIG-M2 PIG-M3 PIG-M4 Camel
D-Glucose + + + + + + + +
D-Fructose + + + + + + + +
D-Mannose + + + + + + + +
D-Maltose + + + + + + + +
D-Lactose + + + + + + + +
D-Trehalose + + + + + + + +
D-Mannitol + + + + + + + +
Xylitol - - - - - - - -
D-Melibiose - - - - - - - -
Potassium Nitrate ? + + + + + + +
β-Naphthyl Phosphate ? + + + + + + +
Sodium Pyruvate ? + + + + + + +
D-Raffinose - - - - - - - -
D-Xylose - - - - - - - -
D-Saccharose + + + + + + + +
Methyl-αD-Glucopyranoside ? - - - - - - -
N-Acetyl-Glucosamine ? +/- +/- - +/- +/- +/- -
L-Arginine + + + + + + + +
Urea + + + + + + + +
Lysostaphin Resistance ? + + + + + + +
IDENTITY CONFIRMATION OF STAPHYLOCOCCUS AUREUS
Staphylococcus aureus












Test Bergey1 WB-2 MLK-78 MLK-182 MLK-1041 MLK-1046 MLK-1021 MLK-1125
D-Glucose + + + + + + + +
D-Fructose + + + + + + + +
D-Mannose + + + + + + + +
D-Maltose + + + + + + + +
D-Lactose + - + + + + + +
D-Trehalose + + + + + + + +
D-Mannitol + + + + + + + +
Xylitol - - - - - - - -
D-Melibiose - - - - - - - -
Potassium Nitrate ? + + + + + + +
β-Naphthyl Phosphate ? + + + + + + +
Sodium Pyruvate ? + + + + + + +
D-Raffinose - - - - - - - -
D-Xylose - - - - - - - -
D-Saccharose + + + + + + + +
Methyl-αD-Glucopyranoside ? - - - - - - -
N-Acetyl-Glucosamine ? +/- +/- +/- +/- + + +/-
L-Arginine + + + + + + + +
Urea + + + + + + + +
Lysostaphin Resistance ? + + + + + + +














Test Bergey1 MLK-1034 MLK-159 JC SM JG IT JB
D-Glucose + + + + + + + +
D-Fructose + + + + + + + +
D-Mannose + + + + + + + +
D-Maltose + + + + + + + +
D-Lactose + + - + - + + +
D-Trehalose + + + + + + + +
D-Mannitol + + + + + + + +
Xylitol - - - - - - - -
D-Melibiose - - - - - - - -
Potassium Nitrate ? + + + + + + +
β-Naphthyl Phosphate ? + + + + + + +
Sodium Pyruvate ? - - + + + + +
D-Raffinose - - - - - - - -
D-Xylose - - - - - - - -
D-Saccharose + + + + + + + +
Methyl-αD-Glucopyranoside ? - - - - - - -
N-Acetyl-Glucosamine ? + +/- +/- + + + +
L-Arginine + + + + + + + +
Urea + + + + + - + +
Lysostaphin Resistance ? + + + + + + +













STAPHYLOCOCCUS AUREUS 16s rDNA NUCLEOTIDE SEQUENCES 
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Scope and Method of Study:  The purpose of this study was to determine the 
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Findings and Conclusions:  The results of the study indicate that it may be 
possible to identify a strain of S. aureus based on the nucleotide or amino 
acid sequence of its enterotoxin.  Comparison of the nucleotide 
sequences of the enterotoxin A genes and the amino acid sequences of 
the translated proteins showed variation between many of the strains of S. 
aureus.  The sequences of some strains were identical; however, in these 
cases the length of 1 sequence was much longer than the other.  Because 
of the discrepancy in length, it is impossible to say that no variations would 
have been observed had the sequences consisted of the same number of 
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